🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Carmody

Southwestern Medical Center

ORCID: 0000-0003-3256-8269

Also affiliated with Mayo Clinic Health System, Southwestern Medical Center, The University of Texas Southwestern Medical Center

MedicinePsychologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.460Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s400591
Top 41%
0.460DataRank
Top 41%12 citations

Betsy D. Kennard, David W. Morris, Ira H. Bernstein, Thomas Carmody, Graham J. Emslie +3 more

Papers

Driven by 21 papers — median percentile 59. Top paper: “Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response”.

Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response

Biological Psychiatry(2022)10.1016/j.biopsych.2022.03.020
N/A
1.2DataRank · unranked
41 citations

Henry W. Chase, Mary L. Phillips, Thilo Deckersbach, Ramin V. Parsey, Maurizio Fava +9 more

Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial

Molecular Psychiatry(2024)10.1038/s41380-024-02468-x
N/A
1.1DataRank · unranked
54 citations

Madhukar H. Trivedi, Richard C. Shelton, Dan V. Iosifescu, Michael E. Thase, Manish K. Jha +17 more

Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD

Kidney360(2020)10.34067/kid.0000062020
N/A
0.513DataRank · unranked
12 citations

Thomas Carmody, Dustin Le, Nina Bharadwaj, Madhukar H. Trivedi, S. Susan Hedayati +1 more

The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s400591
Top 41%
0.460DataRank
Top 41%12 citations

Betsy D. Kennard, David W. Morris, Ira H. Bernstein, Thomas Carmody, Graham J. Emslie +3 more

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR16) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s406909
N/A
0.438DataRank · unranked
14 citations

Alexandra A. Kulikova, Taryn L. Mayes, Karabi Nandy, Thomas Carmody, Gavin Bart +6 more

Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial

Addiction(2024)10.1111/add.16529
N/A
0.430DataRank · unranked
12 citations

Brendon Chau, Thomas R. Belin, Thomas Carmody, Manish K. Jha, Elise N. Marino +3 more

A Comparison of Depressive Symptom Self-Reported Measures in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)

The Journal of Clinical Psychiatry(2023)10.4088/jcp.23m14861
N/A
0.360DataRank · unranked
10 citations

A. John Rush, Thomas Carmody, Beth D. Kennard, Graham J. Emslie, Holli Slater +7 more

Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.110899
N/A
0.269DataRank · unranked
5 citations

Sabrina L Smiley, Phillip O. Coffin, Thomas Carmody, Frances R. Levin, Edward V. Nunes +3 more

Psychometric properties of the Treatment Effectiveness Assessment in methamphetamine use disorder

Journal of Substance Use and Addiction Treatment(2023)10.1016/j.josat.2023.209085
N/A
0.241DataRank · unranked
4 citations

Alexandra A. Kulikova, Taryn L. Mayes, Thomas Carmody, Steven Shoptaw, Walter Ling +3 more

BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained Warping

Brain Connectivity(2022)10.1089/brain.2021.0186
N/A
0.208DataRank · unranked
3 citations

Vyom Raval, Abu Minhajuddin, Thomas Carmody, Madhukar H. Trivedi, Richard B. Dewey +2 more

Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers

Depression and Anxiety(2020)10.1002/da.23006
N/A
0DataRank · unranked
50 citations

A. John Rush, Manish K. Jha, Thomas Carmody, Jennifer L. Furman, Andrew H. Czysz +4 more

Extended Observation of Reduced Methamphetamine Use With Bupropion and Naltrexone Treatment

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.109964
N/A
0DataRank · unranked
0 citations

Brendon Chau, Thomas R. Belin, Thomas Carmody, Manish K. Jha, Elise N. Marino +3 more

Peripheral biological correlates of suicidality in children and adolescents: A systematic review and meta-analysis

iScience(2025)10.1016/j.isci.2025.112290
N/A
0DataRank · unranked
1 citations

Emine Rabia Ayvaci, Thomas Carmody, Limi Jamma, Zihang Feng, Arya Nekovei +3 more

Outcomes From the Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112242
N/A
0DataRank · unranked
0 citations

Udi E. Ghitza, Steven J. Nieto, Erik S. Anderson, Tara G. Chowdhury, Julie M. Croff +7 more

Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study

Mental health and physical activity(2021)10.1016/j.mhpa.2021.100421
N/A
0DataRank · unranked
4 citations

Steven S. Henley, Thomas Carmody, Adriane M. dela Cruz, Tracy L. Greer, Robrina Walker +3 more

Anxiety Scores may Be Associated With Differences in Induction Onto Sublingual Buprenorphine Among Participants With Moderate/Severe Methamphetamine Use Disorder and Opioid Misuse

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112091
N/A
0DataRank · unranked
0 citations

Madhukar H. Trivedi, Udi E. Ghitza, Erik S. Anderson, Tara G. Chowdhury, Julie M. Croff +7 more

Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication

Translational Psychiatry(2021)10.1038/s41398-021-01632-z
N/A
0DataRank · unranked
46 citations

Caroline W. Grant, Duan Liu, Siamak MahmoudianDehkordi, Rima Kaddurah‐Daouk, Michelle Skime +11 more

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder

Frontiers in Pharmacology(2022)10.3389/fphar.2022.984383
N/A
0DataRank · unranked
14 citations

Angelina R. Wilton, Rima Kaddurah‐Daouk, Michelle Skime, Joanna M. Biernacka, Taryn L. Mayes +9 more

Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder

Journal of Personalized Medicine(2022)10.3390/jpm12030412
N/A
0DataRank · unranked
17 citations

Erin F. Barreto, Rakesh Kumar, Rima Kaddurah‐Daouk, Michelle Skime, Taryn L. Mayes +9 more

Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse

Biological Psychiatry(2020)10.1016/j.biopsych.2020.04.009
N/A
0DataRank · unranked
41 citations

Roselinde H. Kaiser, Thilo Deckersbach, Jorge Almeida, Mary L. Phillips, Henry W. Chase +16 more

Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial

Journal of Substance Use and Addiction Treatment(2023)10.1016/j.josat.2023.208987
N/A
0DataRank · unranked
9 citations

Angela L. Stotts, Jin H. Yoon, Thomas F. Northrup, Yolanda R. Villarreal, Luba Yammine +5 more